Is Danggui Safe to be Taken by Breast Cancer Patients?—A Skepticism Finally Answered by Comprehensive Preclinical Evidence

Angelica sinensis (AS, Danggui) has long been regarded to stimulate breast cancer growth; hence, the use of AS in breast cancer patients remains a major concern for both patients and practitioners. Since safety studies of herbs would be unethical to carry out in patients, the present study aimed to...

Полное описание

Библиографические подробности

Главные авторы:	Grace Gar-Lee Yue, Lok-Sze Wong, Hoi-Wing Leung, Si Gao, Julia Yuen-Shan Tsang, Zhi-Xiu Lin, Bonita Ka-Bo Law, Gary Man-Kit Tse, Clara Bik-San Lau
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2019-06-01
Серии:	Frontiers in Pharmacology
Предметы:	breast cancer Angelica sinensis safety estrogenic herbs primary breast cancer cells Chinese herbal medicines
Online-ссылка:	https://www.frontiersin.org/article/10.3389/fphar.2019.00706/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!